n,n-dimethyldoxorubicin has been researched along with aclarubicin in 1 studies
| Studies (n,n-dimethyldoxorubicin) | Trials (n,n-dimethyldoxorubicin) | Recent Studies (post-2010) (n,n-dimethyldoxorubicin) | Studies (aclarubicin) | Trials (aclarubicin) | Recent Studies (post-2010) (aclarubicin) |
|---|---|---|---|---|---|
| 5 | 0 | 1 | 826 | 97 | 105 |
| Protein | Taxonomy | n,n-dimethyldoxorubicin (IC50) | aclarubicin (IC50) |
|---|---|---|---|
| 72 kDa type IV collagenase | Homo sapiens (human) | 9.9 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 1.106 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahle, M; Marquardt, H; Radenz, G; Schaefer, A; Steinheider, G | 1 |
1 other study(ies) available for n,n-dimethyldoxorubicin and aclarubicin
| Article | Year |
|---|---|
Structure-activity relationship between anthracycline-induced differentiation and inhibition of glycoprotein synthesis in Friend erythroleukemia cells.
Topics: Aclarubicin; Animals; Anthracyclines; Antibiotics, Antineoplastic; Cell Differentiation; Cell Line; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Friend murine leukemia virus; Glycoproteins; Hemoglobins; Leukemia, Erythroblastic, Acute; Mannose; Mice; Tunicamycin | 1991 |